ANI Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 2.65 M | $177.19 M | -3.36% | 13.50% |
VANGUARD GROUP INC | 05/09/2025 | 1.18 M | $79.10 M | -10.11% | 6.03% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 818.34 K | $54.79 M | -18.40% | 4.17% |
GLOBAL ALPHA CAPITAL MANAGEMENT LTD. | 05/12/2025 | 735.59 K | $49.25 M | 17.78% | 3.75% |
CITADEL ADVISORS LLC | 05/15/2025 | 723.33 K | $48.43 M | 22.27% | 3.69% |
STATE STREET CORP | 05/15/2025 | 714.57 K | $47.84 M | -3.08% | 3.64% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 700.00 K | $46.87 M | 7.85% | 3.57% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 631.79 K | $42.30 M | -9.70% | 3.22% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 631.56 K | $42.28 M | -7.90% | 3.22% |
RANGER INVESTMENT MANAGEMENT, L.P. | 05/15/2025 | 571.64 K | $38.27 M | -1.06% | 2.92% |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 05/09/2025 | 528.28 K | $35.37 M | 8.86% | 2.69% |
MACQUARIE GROUP LTD | 05/15/2025 | 448.84 K | $30.05 M | -20.22% | 2.29% |
MORGAN STANLEY | 05/15/2025 | 437.45 K | $29.29 M | 93.07% | 2.23% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 429.63 K | $28.77 M | 0.15% | 2.19% |
JPMORGAN CHASE & CO | 05/12/2025 | 422.75 K | $28.30 M | 57.71% | 2.16% |
ABRDN PLC | 05/13/2025 | 419.10 K | $28.06 M | 76.12% | 2.14% |
AMERIPRISE FINANCIAL INC | 05/14/2025 | 390.83 K | $26.17 M | 43.79% | 1.99% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 317.50 K | $21.26 M | 0.00% | 1.62% |
KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2025 | 286.78 K | $19.20 M | 53.95% | 1.46% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 238.38 K | $15.96 M | 0.94% | 1.22% |
THOMPSON SIEGEL & WALMSLEY LLC | 05/09/2025 | 237.03 K | $15.87 M | -16.50% | 1.21% |
D. E. SHAW & CO., INC. | 05/15/2025 | 229.70 K | $15.38 M | 17.00% | 1.17% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 224.68 K | $15.04 M | 9.45% | 1.15% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 219.50 K | $14.70 M | 24.86% | 1.12% |
DEUTSCHE BANK AG\ | 05/09/2025 | 218.09 K | $14.60 M | -6.13% | 1.11% |
NOMURA HOLDINGS INC | 05/15/2025 | 217.18 K | $14.54 M | 1.54% | 1.11% |
NORTHERN TRUST CORP | 05/13/2025 | 216.86 K | $14.52 M | 6.13% | 1.11% |
BANK OF MONTREAL /CAN/ | 05/13/2025 | 215.72 K | $14.44 M | -6.27% | 1.10% |
ROYAL BANK OF CANADA | 05/15/2025 | 210.39 K | $14.09 M | 0.06% | 1.07% |
INVESCO LTD. | 05/12/2025 | 199.57 K | $13.36 M | 1.02% | 1.02% |
MIZUHO MARKETS AMERICAS LLC | 05/12/2025 | 197.47 K | $13.22 M | -1.57% | 1.01% |
LOOMIS SAYLES & CO L P | 05/14/2025 | 193.89 K | $12.98 M | -0.15% | 0.99% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 185.48 K | $12.42 M | 32.01% | 0.95% |
WOODLINE PARTNERS LP | 05/15/2025 | 166.45 K | $11.14 M | 100.00% | 0.85% |
PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 157.80 K | $10.56 M | 68.27% | 0.80% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 140.55 K | $9.41 M | 47.70% | 0.72% |
BARCLAYS PLC | 05/15/2025 | 139.28 K | $9.32 M | -11.32% | 0.71% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 119.26 K | $7.98 M | -3.69% | 0.61% |
ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 114.62 K | $7.67 M | -63.22% | 0.58% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 05/14/2025 | 108.60 K | $7.27 M | 89.93% | 0.55% |
LISANTI CAPITAL GROWTH, LLC | 04/25/2025 | 105.43 K | $7.06 M | 291.77% | 0.54% |
PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2025 | 105.00 K | $7.03 M | 100.00% | 0.54% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 100.16 K | $6.71 M | 41.42% | 0.51% |
SIO CAPITAL MANAGEMENT, LLC | 05/15/2025 | 87.30 K | $5.84 M | -45.46% | 0.45% |
SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 74.99 K | $5.02 M | 100.00% | 0.38% |
MARATHON CAPITAL MANAGEMENT | 05/15/2025 | 69.20 K | $4.63 M | -1.00% | 0.35% |
GREAT LAKES ADVISORS, LLC | 05/16/2025 | 66.84 K | $4.47 M | -9.96% | 0.34% |
AYAL CAPITAL ADVISORS LTD | 05/15/2025 | 66.72 K | $4.47 M | 100.00% | 0.34% |
OBERWEIS ASSET MANAGEMENT INC/ | 05/15/2025 | 65.60 K | $4.39 M | 0.00% | 0.33% |
APIS CAPITAL ADVISORS, LLC | 05/15/2025 | 65.00 K | $4.35 M | 100.00% | 0.33% |
ANI Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 295 institutional investors and hedge funds held shares of ANI Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 2.65 M
VANGUARD GROUP INC: 1.18 M
MILLENNIUM MANAGEMENT LLC: 818,341
Global Alpha Capital Management Ltd.: 735,590
CITADEL ADVISORS LLC: 723,329
STATE STREET CORP: 714,570
101.86% of ANI Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 24.39 M shares in the last 24 months. This purchase volume represents approximately $1.43 B in transactions.